Wikipedia
Tcelna
Tcelna (formerly known as "Tovaxin") is a novel anti- T cell therapeutic vaccine with potential use in treating multiple sclerosis (MS), being developed by Opexa Therapeutics (formerly known as PharmaFrontiers) in The Woodlands, Texas.